Long-Term Follow-Up of Kidney Function after Acute Liver Failure or Acute Liver Injury: A Cohort Study

Author:

Fidalgo Pedro,Póvoa Pedro,Germano Nuno,Karvellas Constantine J.,Cardoso Filipe S.

Abstract

<b><i>Introduction:</i></b> Acute liver failure (ALF) is a rare disease with high mortality. Acute kidney injury (AKI) following ALF is frequent. We assessed AKI impact on long-term kidney function among ALF survivors. <b><i>Methods:</i></b> Observational cohort study including consecutive adult (age ≥16 years) patients with ALF or acute liver injury (ALI) admitted to a Portuguese tertiary center intensive care unit (ICU) between October 2013 and February 2020. KDIGO criteria were used to define AKI and chronic kidney disease (CKD). Primary outcome was the estimated glomerular filtration rate (eGFR), defined by the Chronic Kidney Disease Epidemiology Collaboration formula, at least 1 year after index ICU admission. <b><i>Results:</i></b> Among 104 patients with ALF (<i>n</i> = 74) or ALI (<i>n</i> = 30), mean (SD) age was 43.7 (18.0) years, and 44 were male. Among all patients (<i>n</i> = 104), following adjustment for age and SOFA score, AKI during the first 7 ICU days (<i>n</i> AKI = 57 and <i>n</i> renal replacement therapy [RRT] = 32) was independently associated with all-cause mortality (adjusted HR [95% CI] 11.61 [1.49–90.34]; <i>p</i> = 0.019). Among hospital survivors with long-term kidney function available (<i>n</i> = 56), median (interquartile range) &gt;1 year eGFR was 95.3 (75.0–107.7) mL/min/1.73 m<sup>2</sup> (mean [SD] follow-up of 3.1 [1.6] years). Among these hospital survivors, following adjustment for baseline eGFR, AKI during the first 7 ICU days (<i>n</i> AKI = 19 and <i>n</i> RRT = 10) was not associated with &gt;1 year eGFR (<i>p</i> = 0.15). At least 1 year after index ICU admission, 5 patients developed CKD, none RRT-dependent. <b><i>Conclusions:</i></b> Among ALF or ALI survivors, AKI was not associated with significant long-term loss of kidney function.

Publisher

S. Karger AG

Subject

Gastroenterology,Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3